Company Filing History:
Years Active: 2016
Title: Raphaël Ho Tsong Fang: Innovator in HIV Vaccine Development
Introduction
Raphaël Ho Tsong Fang is a notable inventor based in Paris, France. He has made significant contributions to the field of vaccine development, particularly in relation to HIV. His innovative work focuses on creating immunogenic compounds that can aid in the prevention and treatment of HIV infections.
Latest Patents
One of his key patents is titled "Immunogenic compounds comprising HIV GP41 peptide coupled to CRM197 carrier protein." This invention relates to vaccines aimed at viruses of the HIV family. The immunogenic compound includes a peptide that is covalently linked to a CRM197 protein, enhancing its effectiveness. This patent is crucial for developing compositions that can prevent and treat conditions caused by HIV infections. He holds 1 patent in this area.
Career Highlights
Throughout his career, Raphaël has worked with various companies, including Innavirvax and Minka Therapeutics. His experience in these organizations has allowed him to collaborate with other experts in the field and further his research in immunogenic compounds.
Collaborations
Raphaël has collaborated with notable individuals such as Joël Crouzet and Dominique Desfontaines. These partnerships have contributed to the advancement of his research and the development of innovative solutions in the fight against HIV.
Conclusion
Raphaël Ho Tsong Fang is a prominent figure in the field of vaccine innovation, particularly concerning HIV. His work continues to pave the way for new treatments and preventive measures against this virus.